A major concern in clinical treatment of cancers is resistance of tumors such as hepatocellular carcinoma (HCC) and osteosarcoma to current chemotherapy protocols. Here, we reported that overexpression of second mitochondria-derived activator of caspase (Smac) sensitized osteosarcoma cells and HCC cells in vitro to chemotherapeutic drugs-induced apoptosis. Constitutive expression of Smac resulted in enhanced Bax accumulation on mitochondria upon etoposide stimulation and inhibited Bcl-2-induced antiapoptosis activity. Thus, Smac would sensitize tumor cells to chemotherapeutic drugs in part through promoting Bax translocation to mitochondria and bypassing Bcl-2 block. Moreover, we demonstrated that blockade of Smac expression by antisense smac did not impair etoposide-induced apoptosis; however, p53-induced apoptosis was impaired in smac deficient Saos-2 cell. This suggested Smac might be required in p53-induced apoptosis. Most importantly, complete eradication of HepG2 xenografts in vivo was achieved upon combined therapy with Ad-Smac and 5-Fu. Thus, overexpression of Smac in tumor cells might be a potent strategy for cancer treatment by sensitization of tumor cells to chemotherapeutic drugs.
Introduction
Significant advances in the treatment of cancers have been seen in the past decade. Many new chemotherapeutic agents with few side effects have been developed, undoubtedly, giving rise to improvements in overall survival and quality of life. Despite these advances, however, clinical effectiveness of chemotherapies is still far from satisfactory. New therapeutic regimens are urgently being sought to reduce mortality from this disease. One of the reasons for the failure of chemotherapy treatment is the resistance of tumor cells to these cytotoxic drugs. It has been known that defects in cell apoptotic regulation contribute to induction of drug resistance. 1, 2 The exponential increase in knowledge of cell apoptosis regulated in the molecular level has laid a foundation for the development of apoptosis-targeting therapeutics. 3 There are two major pathways in regulating cell apoptosis, death-receptor pathway and mitochondria pathway. 4 In the death receptor pathway, binding of tumor necrosis factor (TNF)-family receptors with corresponding ligands, such as TNF-related apoptosisinducing ligand (TRAIL) or Fas/CD95 ligand, results in recruitment and activation of procaspase-8. Caspase-8 thereby initiates the subsequent activation of downstream executive caspases. In mitochondria pathway, signals like DNA damage lead to changes in mitochondrial membrane permeability and subsequent release of proapoptotic factors into cytosol. Among these factors, cytochrome c is the most prominent protein. 5 Cytosolic cytochrome c together with Apaf-1 and procaspase-9 forms 'apoptosome', leading to activation of caspase-9. Caspase-9 further activates other caspases and ultimately results in apoptosis.
Another important mitochondria-derived proapoptotic molecule, called Smac (second mitochondria-derived activator of caspase) or DIABLO (direct IAP binding protein with low pI), was recently identified. 6, 7 Smac/ DIABLO significantly eliminates inhibitory effects of inhibitor of apoptosis proteins (IAPs) on caspases. The IAPs suppress apoptosis by directly binding to and inhibiting caspases. 8 The N-terminal tetra-peptide in mature Smac/DIABLO shares significant homology with Nterminal four residues of caspase-9 linker peptide, by which it interacts with XIAP BIR3 domain. 9 Binding of Smac/DIABLO to XIAP antagonizes caspase-XIAP interaction and thereby releases caspases to promote apoptosis. Thus, release of Smac from mitochondria is involved in both mitochondria and death receptor-mediated apoptosis. To develop a new strategy for overcoming the resistance of tumor cells to anticancer drugs, we investigate the role of Smac on apoptosis regulation in vitro and on inhibiting tumor growth in vivo.
Materials and methods

Cell culture
Human osteocarcinoma cell Saos-2 and hepatocellular carcinoma (HCC) cell lines (HCC), HepG2, PLC/PRF/5, HuH-7 and Hep3B were routinely maintained in our laboratory and were propagated in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum at 371C in an atmosphere containing 5% CO 2 .
Chemicals and antibodies
Chemotherapeutic drugs, etoposide and 5-Fluorouracil (5-Fu), and TRAIL protein were purchased from Calbiochem (San Diego, CA). Anti-Smac antibody was kindly provided by Dr Xiaodong Wang (University of Texas, Southwestern Medical Center, TX). Anti-p53, anti-Bax and anti-Bcl-2 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Vector construction and stable transfection
Full-length smac cDNA was kindly provided by Dr Xiaodong Wang (UTSMC, TX). Antisense smac and bcl-2 gene were cloned in mammalian expression vector pcDNA3 (Invitrogen life technologies, Carlsbad, CA). Plasmids were tranfected into Saos-2 cells by Lipofectamine (Invitrogen life technologies, Carlsbad, CA) and stable transfected cells were screened by a routinely procedure at a concentration of 400 mg/ml G418.
Construction, preparation and titering of recombinant adenovirus The construction, preparation and titering of Ad-Smac and Ad-GFP were carried out as described previously. 10 The recombinant viruses were generated with 293 cells and the viral solution was stored at À801C. The titers of viral stocks were determined by spectrophotometry. Viral stocks were diluted 1:20 in 0.1% sodium dodecyl sulfate (SDS)-10 mM Tris-HCl (pH 7.4)-1 mM EDTA and incubated at 561C with a gentle shaking for 10 min. The resulting denatured virus solution was analyzed by spectrophotometry at AD 260 . The viral concentration in particles per milliliter was calculated as ¼ AD 260 Â 20(dilution factor) Â 1.12 Â 10 12 (extinction coefficient).
Measurement of cell viability
Cell viability was determined by trypan blue exclusion assay. HCC cells, HepG2, Hep3B, PLC/PRF/5 and HuH-7 were plated into six-well dishes at a density of 2. DNA fragmentation assay Cells were washed with PBS once and lysed in DNA extract buffer (10 mM Tris, 110 mM EDTA, pH 8.0, 0.5% SDS). Lysate was treated with 20 mg/ml RNase at 371C for 1 h and then, incubated at 561C for 3 h with 100 mg/ml proteinase K, the samples were extracted with phenolchloroform: isoamyl alcohol and concentrated by ethanol precipitation. Finally, the samples were subjected to electrophoresis in 2% agarose gel.
Cytosol and mitochondria fractionation and Western blotting Cells were washed twice with PBS and the pellet was suspended in three volume of ice cold buffer A (20 mM HEPES, pH 7.5, 1.5 mM MgCl 2 , 10mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 10 mg/ ml leupeptin, aprotinin and pepstatin A) containing 250 mM sucrose. Then, the cells were homogenized using Dounce homogenizer and cytosolic or mitochondrial extracts were isolated by centrifugation technique as described previously. 11 Proteins at the same amount were separated by 12% SDS-PAGE and transferred onto PDVF membranes. After probing with individual antibodies, antigen-antibody complex was visualized by enhanced chemiluminescence's reagents Supersigalt (Pierce Biotechnology, Rockford, IL).
Treatment of mice bearing human tumors with Ad-Smac
Balb/c nu/nu female mice (10 to 12 weeks old) were obtained from the Planned Parenthood Research Institute, Shanghai, People's Republic of China. All animals in this study were housed in pathogen-free conditions and were maintained in accordance with the guideline of the Committee on Animals of the Second Military Medical University. HepG2 cells (1 Â 10 7 per mouse) were implanted subcutaneously into the right flank of mice. Animals with growing tumors around 100 mm 3 in volume were sorted randomly into each of groups treated with Ad-Smac plus 5-Fu, Ad-GFP plus 5-Fu, Ad-Smac and Ad-GFP individually (six animals per group). A daily dose of 1 Â 10 9 PFU adenovirus in 50 ml of 1 Â PBS was administered by intratumoral injection at two different sites for 5 days successively. At the day after viral injection, 5-Fu at a dose of 10 mg/kg was administered daily for 5 days via an intraperitoneal route. Following the treatment, tumor development was monitored and tumor size was measured in a blind fashion with calipers and calculated as (length (mm) Â width (mm) 2 )/2, weekly for 10 weeks.
Results
Induction of Smac release by both etoposide and TRAIL-induced apoptosis without involvement of p53 activation Release of Smac from mitochondria to cytosol has been demonstrated in UV-induced apoptosis in Hela cells expressing wild-type p53 gene. 6 Since that, Smac redistribution has been determined in various cell types upon death receptor and genotoxic drugs stimulation.
12, 13 Here, we employed a p53 negative osteosarcoma cell line (p53 gene null), Saos-2, to evaluate the role of p53 in triggering Smac release. Total genomic DNA was extracted from Saos-2 cells before and after treatment with etoposide, DNA fragmentation was observed at 24 h after etoposide exposure ( Figure 1a ). Cytosolic and mitochondrial proteins were isolated from Saos-2 cells with the same treatment and Smac distribution was examined by Western blotting. Expression of Smac was detected predominately in mitochondrial extract and was not detectable in cytosolic fraction in Saos-2 cells before etoposide treatment. However, Smac was released from mitochondria to cytosol upon etoposide treatment for 24 h (Figure 1b) . Cytosolic Smac was also detected in Saos-2 cells following the treatment with 1 mg/ml TRAIL ( Figure  1c ). These results demonstrate that Smac redistribution is a common event in both death receptor-induced and DNA damage-induced apoptosis, which is not associated with expression of p53 gene.
Etoposide-induced apoptosis is not impaired in smac deficient cells
To explore the role of Smac in chemotherapeutic druginduced apoptosis, we generated Saos-2 cells stably expressing smac and antisense smac genes. At 24 h after treatment with etoposide, cytosolic and mitochondrial fraction of proteins were subjected to Western blotting with antibody specific for Smac. Smac expression was obviously enhanced in both cytosol and mitochondria in cells stably expressing Smac, as compared with cells transfected with control vector (Figure 2a) . In contrast, Smac expression was significantly reduced in both fractions of the cells transfected with and expressing antisense smac (Figure 2a) . The cells were also subjected to apoptosis analysis by Annexin V staining. Overexpression of Smac enhanced etoposide-induced apoptosis, with 52.22% of apoptosis cells in smac transfected cells compared to 23.98% in control vector-transfected cells (Po0.01) (Figure 2b ). However, downregulating expression of Smac by antisense smac did not impair etoposide-induced apoptosis. The percentage of apoptotic cells in antisense smac transfected cells was 22.66%, which had no significant difference compared to that in control vector-transfected cells (P40.05). These findings suggest that Smac deficiency may be compensated by action of redundant molecule(s) to kill cells. 
Smac is required in p53-induced apoptosis p53 is the key regulator for apoptosis and cell cycle control. 14, 15 As a cell stress sensor, p53 is activated by DNA damage signals and induces apoptosis through both transcription-dependent and -independent pathway. To investigate the role of Smac in p53-mediated apoptosis, Saos-2 cells were infected with Ad-p53 or control Ad-GFP at MOI 50. At 24 h after infection, the percentage of Sub-G1 cells was 21.21% in Ad-p53 infected cells compared to 2.3% in Ad-GFP infected cells (Figure 3a) . (Figure 3b) . DNA fragmentations induced by Ad-p53 infection were obviously weaker in antisense smac and bcl-2 transfected cells than in control vector-transfected cells upon Ad-p53 infection (Figure 3c ). Immunoblotting analysis showed Smac was released from mitochondria to cytosol in the cells infected with Ad-p53 (Figure 3d) . However, the cytosolic Smac was greatly reduced by bcl-2 or antisense smac expression (Figure 3d ). Bcl-2 and antisense smac might inhibit p53-induced apoptosis by eliminating the effects of cytosolic Smac. These data indicates that p53 induces apoptosis mainly associated with promotion of release of Smac into cytosol and Smac play a key role in p53-induced apoptosis.
Enhancement of translocation of Bax to mitochondria during apoptosis induced by Smac
The importance of Bax in regulating mitochondriamediated apoptosis has been demonstrated previously. 16 Translocation from cytosol to mitochondria is important for Bax to exert its proapoptosis function. 17, 18 However, the role of Smac in Bax-induced apoptosis is not clear. Smac antagonized the antiapoptosis effect of Bcl-2 Bcl-2 family members are the key regulators of mitochondria-mediated apoptosis. 19 Overexpressions of Bcl-2 antiapoptosis family members, like Bcl-2 and Bcl-xL, have been demonstrated to contribute to induction of chemoresistance in many types of human cancers. 2, 20 Transfection of Bcl-2 significantly inhibited the efflux of Smac from mitochondria to cytosol upon etoposide treatment (Figure 5a ). To investigate whether overexpression of Smac would bypass the antiapoptosis effect of Bcl-2, we developed adenoviral Smac expression vector and control GFP vector to infect Saos-2 cells stably expressed Bcl-2. At 48 h after infection, Ad-Smac induced DNA fragmentation can be observed both in the cells overexpressing Bcl-2 and in cells infected with control vector (Figure 5b ). More importantly, Smac expression in both mitochondria and cytosol of Bcl-2 transfected cells was significantly increased following Ad-Smac infection as compared with that in Ad-GFP transfected cells (Figure 5c ). These results demonstrated Bcl-2 might inhibit apoptosis through blocking the release of Smac from mitochondria to cytosol and overexpression of Smac could antagonize the antiapoptosis effect of Bcl-2.
Smac sensitized HCC cells to etoposide-induced apoptosis in vitro HCC is one of the most common cancers in the world, especially in Asia. The failure of HCC treatments is mainly due to tumor recurrence and resistance to existing chemotherapies. Abnormal expression of Bcl-2 family proteins, like Bcl-xL, has been observed in HCC cell lines and surgically resected tumor tissues, which contributes to induction of chemoresistance of HCC. 21, 22 To investigate whether overexpression of Smac would enhance the chemo-sensitivity of HCC cells to cytotoxic or DNAdamaging induced drugs, we infected HCC cell lines HepG2, Hep3B, PLC/PRF/5 and HuH-7, which express high levels of Bcl-xL, 21 with Ad-Smac or Ad-GFP at a dose of MOI 50. 
Discussion
Anticancer drugs are classified as DNA-damaging agents, antimetabolites, mitotic inhibitors, nucleotide analogues or inhibitor of topoisomerases. Etoposide is a topoisomerase II inhibitor, which exerts its antineoplastic effect by interruption of DNA replication and transcription and causes accumulation of double-strand breaks within the nuclei of cells. 23 Cells recognize such DNA damage through distinct pathway and, in turn, to eliminate the injured cells by apoptosis. A key element in stress-induced apoptosis is p53, and etoposide-induced apoptosis and cytochrome c release is also associated with activation of p53. 24 However, the upstream sensor for initiating Smac release upon DNA-damaging stress is not clear. Here, we employed an osteosarcoma cell line with p53 gene null, Saos-2, to evaluate the role of p53 in Smac release upon etoposide induction. Smac was released from mitochondria in Saos-2 cells after etoposide treatment, which was not associated with p53 activation. This indicates the release of Smac from mitochondria upon etoposide induction is independent of p53.
Whether cytochrome c involved in p53-mediated apoptosis remains unclear 25, 26 and the role of Smac in p53-mediated apoptosis still need to be identified. We showed that Smac was released from mitochondria by overexpression of p53 and blockade of Smac expression with antisense smac attenuated p53-induced apoptosis. It has been known that embryonic fibroblasts (MEFs) from Smac deficient mice exhibit normal apoptosis response as in Smac þ / þ MEFs upon UV irradiation, chemotherapeutic drugs treatment or oncogene overexpression. 27 However, whether Smac deficiency would impair p53-induced apoptosis is subject to explore. In this report, we reported that blockade of Smac expression by antisense technique did not impair etoposide-induced apoptosis in Saos-2 cell, which was consistence with the observation in Smac À/À MEFs 27 and apoptosis induced by Ad-p53 was attenuated by downregulation of Smac expression. These results clearly indicate Smac release is involved in p53-induced apoptosis. Smac plays a role and is required in p53-induced apoptosis.
Bcl-2-family members are the key regulators of mitochondria-mediated apoptosis through regulation of the mitochondrial membrane permeability. 19 Antiapoptotic proteins, like Bcl-2 and Bcl-xL, exert their effects mainly by blocking the proapoptotic signalings of proapoptotic Bcl-2 proteins, like Bax and Bak. Bax is a cytosolic monomer in healthy cells, but it changes molecular confirmation and is present as a high molecular weight oligomer/complex in the mitochondrial membrane during apoptosis. 28, 29 The proapoptotic effect of Bax is believed to initiate by its interaction with the mitochondria and its insertion into the outer mitochondrial membrane particularly. 30, 31 Evidence suggests that Bax induces apoptosis by promoting cytochrome c release from mitochondria 32, 33 and overexpression of Bax is essential for release of Smac from mitochondria to cytosol. During etoposide treatment, endogenous Bax was accumulated on the mitochondria leading to the release of Smac from mitochondria, which suggests Smac release is involved in the Bax-induced apoptosis. Moreover, we found overexpression of Smac enhanced Bax accumulation on mitochondria upon etoposide induction and blockade of Smac expression by antisense smac Figure 6 Smac sensitized HCC cells to etoposide-induced apoptosis in vitro. HCC cell lines, HepG2, HuH7, PLC/PRF/5 and Hep3B, were infected with Ad-GFP or Ad-Smac at MOI 50 and were incubated with or without 8 mg/ml etoposide fro 24 h. The cells were stained with trypan blue and the numbers of cell death were counted under microscope. The data represent three independent experiments. 9 PFU Ad-GFP or Ad-smac was performed for 5 consecutive days. 5-Fu at a dose of 10 mg/kg body weight was introperitoneally administered daily for 5 days starting at day 2 after adenovirus administration. Animals were monitored daily and tumor volumes were measured weekly.
inhibited Bax accumulation on mitochondria. Thus, Smac might sensitize tumor cells to chemotherapeutic drugs in part by promoting Bax accumulation on mitochondria. Although antisense smac was able to inhibit the expression of Bax on mitochondria upon etoposide induction, etoposide-induced apoptosis was not impaired by antisense smac, suggesting that redundant molecules in cells might compensate for the cell killing through activation of proapoptosis genes other than bax.
Overexpression of antiapoptosis Bcl-2-family members, like Bcl-2 and Bcl-xL, has been found in many tumors including HCC, which contributes to tumor resistance to chemotherapy. 2, [20] [21] [22] Here, we showed that release of Smac from mitochondria upon etoposide induction was blocked by Bcl-2. However, overexpression of Smac by adenovirus vector bypassed the Bcl-2 blockade and induced apoptosis in bcl-2 transfected Saos-2 cell line. 
